Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy

Sina Haeri, Marla Shauer, Monica Dale, Virginia (Jennie) Leslie, Arthur M. Baker, Stephanie Saddlemire, Kim Boggess

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Objective: Our aim was to examine perinatal outcomes in women who are infected with human immunodeficiency virus (HIV) and who receive highly active antiretroviral therapy compared with the general population. Study Design: In this retrospective cohort study, we compared 151 HIV-positive and 302 HIV-negative women. We defined highly active antiretroviral therapy as concomitant use of at least 3 antiretroviral drugs. We calculated frequencies and odds ratios for adverse pregnancy outcomes. Results: Compared with control subjects, smoking (odds ratio, 4.62; 95% confidence interval [CI], 2.58-8.27), drug abuse (odds ratio, 5.48; 95% CI, 2.21-13.59), and spontaneous preterm birth (adjusted odds ratio, 2.27; 95% CI, 1.22-4.25) were more common among HIV-positive women. HIV-positive women were more likely to deliver a small-for-gestational-age infant, but this was due to higher tobacco and cocaine use. Neonatal outcomes were otherwise similar. Conclusion: HIV-positive women are at increased risk for preterm birth and lower birthweight infants; therefore, antenatal surveillance should include fetal growth assessment. Highly active antiretroviral therapy use does not increase maternal complications.

Original languageEnglish (US)
JournalAmerican Journal of Obstetrics and Gynecology
Volume201
Issue number3
DOIs
StatePublished - Sep 2009
Externally publishedYes

Fingerprint

Highly Active Antiretroviral Therapy
Obstetrics
HIV
Newborn Infant
Odds Ratio
Premature Birth
Confidence Intervals
Small for Gestational Age Infant
Tobacco Use
Pregnancy Outcome
Fetal Development
Cocaine
Substance-Related Disorders
Cohort Studies
Retrospective Studies
Smoking
Mothers
Pharmaceutical Preparations
Population

Keywords

  • highly active antiretroviral therapy
  • human immunodeficiency virus
  • low birthweight
  • pregnancy
  • preterm birth

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy. / Haeri, Sina; Shauer, Marla; Dale, Monica; Leslie, Virginia (Jennie); Baker, Arthur M.; Saddlemire, Stephanie; Boggess, Kim.

In: American Journal of Obstetrics and Gynecology, Vol. 201, No. 3, 09.2009.

Research output: Contribution to journalArticle

Haeri, Sina ; Shauer, Marla ; Dale, Monica ; Leslie, Virginia (Jennie) ; Baker, Arthur M. ; Saddlemire, Stephanie ; Boggess, Kim. / Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy. In: American Journal of Obstetrics and Gynecology. 2009 ; Vol. 201, No. 3.
@article{1dd930b0e28548e5a93da835e08a03d2,
title = "Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy",
abstract = "Objective: Our aim was to examine perinatal outcomes in women who are infected with human immunodeficiency virus (HIV) and who receive highly active antiretroviral therapy compared with the general population. Study Design: In this retrospective cohort study, we compared 151 HIV-positive and 302 HIV-negative women. We defined highly active antiretroviral therapy as concomitant use of at least 3 antiretroviral drugs. We calculated frequencies and odds ratios for adverse pregnancy outcomes. Results: Compared with control subjects, smoking (odds ratio, 4.62; 95{\%} confidence interval [CI], 2.58-8.27), drug abuse (odds ratio, 5.48; 95{\%} CI, 2.21-13.59), and spontaneous preterm birth (adjusted odds ratio, 2.27; 95{\%} CI, 1.22-4.25) were more common among HIV-positive women. HIV-positive women were more likely to deliver a small-for-gestational-age infant, but this was due to higher tobacco and cocaine use. Neonatal outcomes were otherwise similar. Conclusion: HIV-positive women are at increased risk for preterm birth and lower birthweight infants; therefore, antenatal surveillance should include fetal growth assessment. Highly active antiretroviral therapy use does not increase maternal complications.",
keywords = "highly active antiretroviral therapy, human immunodeficiency virus, low birthweight, pregnancy, preterm birth",
author = "Sina Haeri and Marla Shauer and Monica Dale and Leslie, {Virginia (Jennie)} and Baker, {Arthur M.} and Stephanie Saddlemire and Kim Boggess",
year = "2009",
month = "9",
doi = "10.1016/j.ajog.2009.06.017",
language = "English (US)",
volume = "201",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy

AU - Haeri, Sina

AU - Shauer, Marla

AU - Dale, Monica

AU - Leslie, Virginia (Jennie)

AU - Baker, Arthur M.

AU - Saddlemire, Stephanie

AU - Boggess, Kim

PY - 2009/9

Y1 - 2009/9

N2 - Objective: Our aim was to examine perinatal outcomes in women who are infected with human immunodeficiency virus (HIV) and who receive highly active antiretroviral therapy compared with the general population. Study Design: In this retrospective cohort study, we compared 151 HIV-positive and 302 HIV-negative women. We defined highly active antiretroviral therapy as concomitant use of at least 3 antiretroviral drugs. We calculated frequencies and odds ratios for adverse pregnancy outcomes. Results: Compared with control subjects, smoking (odds ratio, 4.62; 95% confidence interval [CI], 2.58-8.27), drug abuse (odds ratio, 5.48; 95% CI, 2.21-13.59), and spontaneous preterm birth (adjusted odds ratio, 2.27; 95% CI, 1.22-4.25) were more common among HIV-positive women. HIV-positive women were more likely to deliver a small-for-gestational-age infant, but this was due to higher tobacco and cocaine use. Neonatal outcomes were otherwise similar. Conclusion: HIV-positive women are at increased risk for preterm birth and lower birthweight infants; therefore, antenatal surveillance should include fetal growth assessment. Highly active antiretroviral therapy use does not increase maternal complications.

AB - Objective: Our aim was to examine perinatal outcomes in women who are infected with human immunodeficiency virus (HIV) and who receive highly active antiretroviral therapy compared with the general population. Study Design: In this retrospective cohort study, we compared 151 HIV-positive and 302 HIV-negative women. We defined highly active antiretroviral therapy as concomitant use of at least 3 antiretroviral drugs. We calculated frequencies and odds ratios for adverse pregnancy outcomes. Results: Compared with control subjects, smoking (odds ratio, 4.62; 95% confidence interval [CI], 2.58-8.27), drug abuse (odds ratio, 5.48; 95% CI, 2.21-13.59), and spontaneous preterm birth (adjusted odds ratio, 2.27; 95% CI, 1.22-4.25) were more common among HIV-positive women. HIV-positive women were more likely to deliver a small-for-gestational-age infant, but this was due to higher tobacco and cocaine use. Neonatal outcomes were otherwise similar. Conclusion: HIV-positive women are at increased risk for preterm birth and lower birthweight infants; therefore, antenatal surveillance should include fetal growth assessment. Highly active antiretroviral therapy use does not increase maternal complications.

KW - highly active antiretroviral therapy

KW - human immunodeficiency virus

KW - low birthweight

KW - pregnancy

KW - preterm birth

UR - http://www.scopus.com/inward/record.url?scp=69349103203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69349103203&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2009.06.017

DO - 10.1016/j.ajog.2009.06.017

M3 - Article

C2 - 19733286

AN - SCOPUS:69349103203

VL - 201

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 3

ER -